Ipca Labs reports Q3 net profit at Rs 88 cr

Jump in net on the back of strong sales across domestic and international markets.

Drug firm Ipca Laboratories posted a net profit of Rs 87.89 crore for the third quarter ended December 31, 2012 on the back of strong sales across domestic and international markets.

The company had posted a net profit of Rs 63.93 crore during the same period of previous fiscal.

Net sales of the company stood at Rs 692.41 crore during the third quarter ended December 31, 2012. The company's net sales during the same period of previous fiscal stood at Rs 601.78 crore, Ipca Laboratories said in a filing to the BSE.

The results for the quarter ended December 31, 2012 are not comparable to the figures of same period of previous financial year due to the merger of Tonira Pharma with the company, it added.

 

During the period under review, the company's sales from domestic formulations business stood at Rs 212.73 crore, while the income from exports stood at Rs 442.37 crore.

Shares of Ipca Labs were trading at Rs 481 on the BSE in afternoon trade, down 1.40% from their previous close. PTI MSS STS tvs